Compare BAX & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BAX | CRL |
|---|---|---|
| Founded | 1931 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.6B |
| IPO Year | 1994 | 1999 |
| Metric | BAX | CRL |
|---|---|---|
| Price | $22.06 | $214.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $21.00 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 6.4M | 752.4K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,244,000,000.00 | $1,857,601,000.00 |
| Revenue This Year | $1.96 | N/A |
| Revenue Next Year | $2.22 | $3.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 5.72 | ★ 10.48 |
| 52 Week Low | $15.73 | $144.26 |
| 52 Week High | $31.76 | $228.88 |
| Indicator | BAX | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 69.64 | 73.04 |
| Support Level | $21.61 | $193.41 |
| Resistance Level | $22.41 | $228.64 |
| Average True Range (ATR) | 0.72 | 7.45 |
| MACD | 0.13 | 2.68 |
| Stochastic Oscillator | 95.20 | 92.13 |
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.